Researchers Develop CRISPR-Based Test for Rapid Leukemia Diagnosis
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Leukemia |
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Oct 8, 2024 | Leukemia, Sequencing Systems |
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read MorePosted by Andy Lundin | Oct 4, 2024 | Sepsis |
Abionic’s IVD CAPSULE PSP test gained FDA 510(k) clearance to rapidly detect sepsis, marking the company’s expansion into the U.S. market.
Read MorePosted by Andy Lundin | Sep 30, 2024 | Anatomic Pathology, Cancer |
A novel pathology tool uses DNA barcoding to map RNA and proteins in tissue, offering a potential breakthrough in cancer diagnosis.
Read MorePosted by Andy Lundin | Sep 27, 2024 | Infectious Diseases, Molecular Diagnostics |
The Molecular Culture ID is a new diagnostic test that rapidly detects and identifies over 200 bacterial species from various bodily samples.
Read More